This solicitation is a request for quotes (RFQ). The solicitation documents and incorporated provisions and clauses are those in effect through Federal Acquisition Circular (FAC) 2005-100, dated August 22, 2018. The associated North American Industry Classification System (NAICS) code for this procurement is 325414 with a small business size standard of 1250.
The National Institute of Allergy and Infectious Diseases (NIAID), is seeking Expifectamine Tranfxn Kit and EXPI293 Expression Medium. No substitutions allowed. Brand Name/Contractor must be a ThermoFisher/Life Technologies authorized reseller by RFQ close. Please see attached Bill of Materials (BOM).
Period of Performance (POP): October 1, 2018 - September 30, 2019
The award will be based on the following; price, capability to meet the requirements, delivery and the best value to the government.
The Government intends to award without discussions, but reserves the right to conduct discussions should it be deemed in the Government's best interest.
The following FAR provisions apply to this acquisition:
FAR 52.212-1 Instructions to Offerors Commercial Items (Jan 2017)
FAR 52.212-3 Offerors Representations and Certifications - Commercial Items (Nov 2017) Offerors must complete annual representations and certifications on-line at http://www.sam.gov in accordance with FAR 52.212-3 Offerors Representations and Certifications- Commercial Items
The following contract clauses apply to this acquisition:
FAR 52.212-4 Contract Terms and Conditions Commercial Items (Jan 2017)
FAR 52.212-5 Contract Terms and Conditions Required to Implement Statutes or Executive Orders Commercial Items (Aug 2018)
FAR 52.232-40 Providing Accelerated Payments to Small Business Subcontractors (Dec 2013)
FAR 52.222-48 -Exemption from Application of the Service Contract Labor Standards to Contracts for Maintenance, Calibration, or Repair of Certain Equipment -- Certification. (May 2014)
HHSAR 352.203-70 Anti-Lobbying (Dec 2015)
HHSAR 352.239-74 Electronic and Information Technology Accessibility (Dec 2015).
HHSAR 352.222-70 Contractor Cooperation in Equal Employment Opportunity Investigations (December 18, 2015)
The applicable subparagraphs of FAR52.212-5 are included in the attachment to this posting.
Quoter must include the following provision in their quote and check the appropriate response.
52.209-2 -- Prohibition on Contracting with Inverted Domestic Corporations--Representation. (Nov 2015)
(a) Definitions. "Inverted domestic corporation" and "subsidiary" have the meaning given in the clause of this contract entitled Prohibition on Contracting with Inverted Domestic Corporations (52.209-10).
(b) Government agencies are not permitted to use appropriated (or otherwise made available) funds for contracts with either an inverted domestic corporation, or a subsidiary of an inverted domestic corporation, unless the exception at 9.108-2(b) applies or the requirement is waived in accordance with the procedures at 9.108-4.
(c) Representation. By submission of its offer, the offeror represents that- (check one)
____(1) It is not an inverted domestic corporation: and
____(2) It is not a subsidiary of an inverted domestic corporation
By submission of an offer, the offeror acknowledges the requirement that a prospective awardee shall be registered in the System for Award Management (SAM) database prior to award, during performance, and through final payment of any contract, basic agreement, basic ordering agreement, or blanket purchasing agreement resulting from this solicitation (www.sam.gov).
This is an open-market combined synopsis/solicitation for Expifectamine Tranfxn Kit and EXPI293 Expression Medium as defined herein. The government intends to award a purchase order as a result of this combined synopsis/solicitation that will include the terms and conditions set forth herein. To facilitate the award process all quotes should include a statement regarding the terms and conditions herein as follows: "The terms and conditions in the solicitation are acceptable to be included in the award document without modification, deletion or addition." OR "The terms and conditions in the solicitation are acceptable to be included in the award document with the exception, deletion, or addition of the following:" (Quoter shall list exception(s) and rationale for the exception(s).)
Offers may be e-mailed to [email protected]. Late submissions shall be treated in accordance with the solicitation provision at FAR 52.212-1(f).